A high rate of venous thromboembolism in a multi-institutional Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

A high rate of venous thromboembolism in a multi-institutional Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma

Published:2002-10-03 Issue:8 Volume:95 Page:1629-1636
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Desai Apurva A.,Vogelzang Nicholas J.,Rini Brian I.,Ansari Rafat,Krauss Stuart,Stadler Walter M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference43 articles.

1. Cancer Statistics, 2001

2. Epidemiology of renal cell carcinoma. In: editors. Comprehensive textbook of genitourinary oncology, 2nd ed. Philadelphia: Lippincott Williams and Wilkins, 2000: 1010-1100.

3. Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

4. Kidney cancer

5. SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on Probable Causes of Cardiotoxicity Caused by Common Cancer Drugs and the Role of Traditional Chinese Medicine in Prevention and Treatment;Pharmacogenomics and Personalized Medicine;2023-12

2. Chemotherapy Induced Cardiotoxicity: A State of the Art Review on General Mechanisms, Prevention, Treatment and Recent Advances in Novel Therapeutics;Current Problems in Cardiology;2023-04

3. Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19;HemaSphere;2021-06

4. An overview of thrombotic complications of old and new anticancer drugs;Thrombosis Research;2020-07

5. Clinical trials on combination of repurposed drugs and anticancer therapies;Drug Repurposing in Cancer Therapy;2020